NCT04283773View on ClinicalTrials.gov

Immunohistochemical Evaluation of Protein P16 Expression in Ovarian Germ Cell Tumors.

CompletedOBSERVATIONAL
Enrollment

62

Participants

Timeline

Start Date

December 24, 2019

Primary Completion Date

April 1, 2021

Study Completion Date

April 1, 2021

Conditions
Ovarian NeoplasmsGerm Cell TumorsImmunohistochemistry
Interventions
COMBINATION_PRODUCT

p16INK4a Recombinant Rabbit Monoclonal Antibody (RM267)

Treatment of slides that cut from paraffin embedded blocks related to groups by immunohistochemical method by p16INK4a Recombinant Rabbit Monoclonal Antibody (RM267).

COMBINATION_PRODUCT

Ki67 antibody (DAKO) for malignant cases only

Treatment of slides that cut from paraffin embedded blocks related to malignant case group by immunohistochemical method by Ki67 antibody.

Trial Locations (1)

71111

Assiut University, Asyut

All Listed Sponsors
lead

Assiut University

OTHER

NCT04283773 - Immunohistochemical Evaluation of Protein P16 Expression in Ovarian Germ Cell Tumors. | Biotech Hunter | Biotech Hunter